Ibalizumab in Multidrug-Resistant HIV - Accepting Uncertainty

Sheikh, V; Murray, JS; Sherwat, A

Sheikh, V (reprint author), US FDA, Div Antiviral Prod, Off Antimicrobial Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2018; 379 (7): 605